LDL Particles Are Nonspherical: Consequences for Size Determination and Phenotypic Classification
To the Editor: The recent article by Ensign et al. (1 ) , reporting on a disappointingly low agreement among 4 methods to assess LDL particle size and phenotypic classification, casts doubt on the utility of these techniques in clinical practice. A similar poor correlation (r ϭ 0.39) between LDL size measurements by nuclear magnetic resonance (NMR) and gradient gel electrophoresis (GGE) has been reported by Witte et 
al. in a study with 324 individuals (2 ). Ensign et al. (1 )
advocate a standardization program to reduce the lack of concordance between methods. In addition to standardization problems, however, there is another reason for the observed discrepancy that is not addressed in the Ensign paper and accompanying editorial; the assumption that LDL size is adequately described by a single variable, diameter.
We would like to point out that this assumption may not be valid for LDL particle size. The situation is akin to the quantification of obesity, for which several measures are commonly used, such as body mass index, waist circumference, and waist-to-hip ratio. Although these measures are significantly correlated, they cannot be used interchangeably. If humans were spherical objects, the agreement between these measures of obesity would be perfect. But this is obviously not the case, because human beings come in all sorts of shapes. We think that to a certain extent this is also true for LDL particles. Although a spherical shape may seem intuitively right, several experimental approaches have not confirmed this characteristic of LDL particles but instead suggest that they are nonspherical. Nonspherical shape is not unique to LDL particles, but also occurs within the HDL class of lipoproteins. Although mature HDL particles are spherical, it is well accepted that nascent HDL particles are discoidal.
The fact that each LDL particle contains a single copy of apolipoprotein B-100, almost fully accounting for the protein content of LDL, allows straightforward calculation of average LDL particle volume from its chemical composition (3 ) . Assuming a spherical particle shape, average diameter can then be calculated by simple arithmetic. In a study including 160 individuals, we observed that LDL diameters measured by high-performance gel-filtration chromatography correlated poorly (r ϭ 0.60) with calculated diameters (3 ) . This discrepancy could be reconciled by assuming that LDL particles are discoidal, with a mean diameter of 20.9 nm (range 19.6 -21.6 nm) and a mean height of 12.1 nm (range 10.5-13.9 nm) (3 ) . These values are in striking agreement with dimensions obtained by cryoelectron microscopy, which is a technique allowing visualization of single LDL particles from different angles (4 ) . Furthermore, data obtained by crystallographic analysis are also indicative of a pseudocylindrical or discoidal particle shape (5 ) .
An important consequence of the discoidal LDL model is that techniques that are currently used to assess LDL size are not equivalent. Techniques such as dynamic light scattering and NMR actually measure particle volume, from which diameter is calculated, assuming a spherical particle shape. This principle also applies to density gradient ultracentrifugation, because density is inversely proportional to particle volume. In contrast, measurements by high-performance gel-filtration chromatography and electrophoretic techniques such as GGE and tube gel electrophoresis probably reflect particle diameter more closely. A striking feature of the discoidal particle model is that diameter and height are not significantly correlated (3 ). Consequently, a flat particle of large diameter can have the same volume as a thick particle of small diameter, resulting in similar NMR readings but widely differing GGE results.
In conclusion, we suggest that the lack of agreement between various methods to assess LDL particle size or phenotype is partly due to the fact that LDL particles are not spherical and therefore their size cannot be described by a single variable. In addition to partly resolving the perceived discrepancy between LDL size measurements, the discoidal particle concept puts a new perspective on the notion that small, dense LDL are more atherogenic than their large counterparts. Clinically, discoidal particle shape raises the question of what measure of LDL size or shape-volume, diameter, height, or aspect ratio-is most closely related to cardiovascular disease, an evaluation process reminiscent of the ongoing discussion of whether body mass index or waist circumference is a better predictor of cardiovascular outcome. Unfortunately, in contrast to these anthropometric measures, which are readily performed on large numbers of individuals, measurement of LDL dimensions is not easily performed on a large scale. Nevertheless, we do think that it would shed more light on the relative atherogenicity of specific LDL subclasses.
A Case of IgM Paraproteinemia in Which Serum Free Light Chain Values Were Within Reference Intervals

To the Editor:
We read with interest the recent paper on the combination of serum protein electrophoresis (SPEP) and serum free light chain (FLC) assay as a potential alternative to SPEP and urine protein electrophoresis (UPEP) screening for paraproteinemia (1 ), as well as the accompanying editorial on sensitivity and specificity issues of the serum FLC assay (2 ). This assay, which first became commercially available in 2001, is used to diagnose and monitor light chain myeloma, primary amyloidosis, and related light chain diseases. Despite the usually quoted high clinical sensitivity of serum FLC assay in detecting light chain disease, results within reference intervals can occur with intact immunoglobulin paraproteinemia (3 ). We describe a patient with IgM paraproteinemia who showed FLC concentrations and : ratio within reference intervals.
A 79-year old Chinese woman presented with blurred vision due to hyperviscosity syndrome and bleeding tendency. Physical examination showed no hepatosplenomegaly or lymphadenopathy. Complete blood counts showed hemoglobin of 78 g/L, 8.3 ϫ 10 9 leukocytes/L and 110 ϫ 10 9 platelets/L. The patient's blood smear showed obvious erythrocyte rouleaux formation in association with 6% circulating plasma cells. The total globulin concentration was markedly increased at 115 g/L, but renal and liver biochemistry tests were unremarkable. No hypercalcemia was apparent, and a skeletal survey showed no osteolytic le- IgM paraproteinemia is seen in Waldenströ m macroglobulinemia, Bcell lymphoma or lymphoproliferative disorders, monoclonal gammopathy of undermined significance (MGUS), -heavy chain disease, and IgM myeloma. Our patient was unusual in that the paraprotein most probably consisted of only intact IgM molecules with no excess FLC, thus explaining the normal serum FLC concentration and ratio. The diagnostic performance of serum FLC assay has been evaluated in patients with plasma cell disorders (4 ) including IgM paraproteins, including macroglobulinemia, IgM lymphoproliferative disorder, and lymphoma, but no detailed breakdown of data was available in this subgroup. In another study, among 37 patients with Waldenströ m macroglobulinemia, all but one had abnormal FLC concentrations and/or an abnormal : ratio (3 ). Furthermore, FLC concentrations were reported to be within reference values in ϳ4% of intact Ig multiple myeloma and in 40% of MGUS at presentation (5 ) . Thus although the serum FLC assay may allow identification of additional monoclonal FLC-producing individuals, the test must be interpreted in conjunction with SPEP with or without immunofixation, especially in the setting of paraprotein screening. This patient serves as a reminder that FLC assays cannot replace SPEP as a screening test but can identify additional patients with light disease that may be missed by a combination of SPEP and UPEP. It would be of interest to extend our case observation to more patients with IgM paraproteinemia to document the frequency and any associated clinical significance of normal : ratios.
